The author outlines an analytical strategy for establishing similarity in biosimilar development and approval.
Mario DiPaola
Advertisement
Mario DiPaola is senior scientific director at Charles River Laboratories in Woburn, MA.
Articles by Mario DiPaola
Advertisement
Latest Updated Articles
Analytical Strategy in the Development of BiosimilarsPublished: August 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
